PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor
A transcutaneous monitor specially designed for assessing tissue oxygen
- Reproducible TCOM test protocols
- Personalised and ready-to-use reports
- Up to 8 sensors of tcpO2 measurement
Transcutaneous monitoring tailored to your needs
Reveal wound healing capacity with the PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor.
PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor can support you in assessing patients with lower extremity wounds.
With a transcutaneous measurement of oxygen from the tissue, you can measure the microcirculation of the patient's limbs.
A transcutaneous monitoring solution with reproducible TCOM test protocols
The transcutaneous monitor has several different test protocols. The preloaded transcutaneous oxygen measurement (TCOM) test protocols ensure reproducibility of measurement of the patient and across teams.
The instructions displayed on the touch screen interface guide you along each step, from patient preparation to the different steps of measurement.
You can take the small and portable stand-alone monitor with you. Alternatively, place it on a stand or a cart.
Transcutaneous monitor with eight TCOM sensors
This provides you with a more comprehensive coverage of the wound’s surroundings. It allows you to accelerate the measurement, getting a more accurate map of the extremity.
Use Radiometer E5250 tcpO2 sensors with the PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor.
With the sensors, you get relevant data that can support you in assessing your patient with peripheral artery disease.
Streamlined data capture
The transcutaneous monitor includes a camera for TCOM documentation. In addition to tcpO2 values, you get a mapping of the sensors around the wound area.
You also get an automatically generated report which can include patient information, TCOM values and a picture of the sensors' positions around the wound. Decide which field entries are included in the report and personalise the report by inserting your hospital logo.
Patient data integrity
Access to the PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor can be password-protected. Its hard drive can also be encrypted. The audit trail tracks who accesses the monitor and lists related activities.
These features support you in your compliance needs. You can also better protect sensitive patient information.
PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor is compliant with the Health Insurance Portability and Accountability Act (HIPAA).
Cookies are used on this website
Use of cookiesPlease enter a valid email
We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.
It seems that your e-mail is not registered with us
Please click "Get started" in the e-mail to complete the registration process
Radiometer is using Microsoft AZURE Active Directory to authenticate users
Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.
If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.
Key benefits
- Allow the use of existing Active Directory credentials
- Single-sign on experience
- Use same credentials to access future services
Request access
You will receive an invitation to access our services via e-mail when your request has been approved.
When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.